CD4 and myeloid sarcoma: Prior research has demonstrated that in MS patients, CD8+ T cells proliferate more than CD4+ T cells, which is mainly linked to axon damage (Khan et al., 2024; Dong et al., 2021; Dadfar et al., 2024).